| Stage | FCN | % of rev | BAH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.0B | 100.00% | $2.8B | 100.00% | BAH ×2.74 |
| Gross profit | $351M | 34.64% | $1.4B | 52.02% | BAH +17.4pp |
| Operating income | $90M | 8.87% | $245M | 8.82% | FCN +0.1pp |
| Pre-tax income | $77M | 7.63% | $199M | 7.16% | FCN +0.5pp |
| Net income | $63M | 6.27% | $181M | 6.52% | BAH +0.2pp |
| Stage | FCN | BAH | Gap · A − B |
|---|---|---|---|
| Revenue | $1.0B100.00% | $2.8B100.00% | BAH ×2.74 |
| Gross profit | 34.64%$351M | 52.02%$1.4B | BAH +17.4pp |
| Operating income | 8.87%$90M | 8.82%$245M | FCN +0.1pp |
| Pre-tax income | 7.63%$77M | 7.16%$199M | FCN +0.5pp |
| Net income |
| 6.27%$63M |
| 6.52%$181M |
| BAH +0.2pp |
None
No disclosed counterparties: FCN.